×

RNS Number : 1983N

Osirium Technologies PLC

23 September 2019

 

23 September 2019

 

 

Osirium Technologies plc

 

("Osirium" or "Group")

 

Substantial contract win with major UK provider of software and IT services

 

Osirium Technologies plc (AIM: OSI.L), a leading vendor of cloud-based cybersecurity software, is pleased to announce a significant contract win with a major UK provider of software and IT services to the public sector. The contract represents a substantial expansion by this customer of its investment in Osirium, following an initial order, as announced on 12 February.

 

Under the terms of the contract, Osirium will deliver its full PxM Platform including the Privileged Access Management, Privileged Task Management and Privileged Session Management modules. The 36 month license is for 2,600 devices, in addition to the 250 devices covered by the initial order. Osirium's software will enable this service provider to deliver managed security services to its customers, principally central government organisations and local authoriities in the public sector, delivering rigorous control of access to privileged accounts.

 

David Guyatt, Chief Executive Officer, commented: "Osirium is delighted that, within a 9 month period, this prominent service provider has shown such confidence in the Osirium solution and expanded its base of protected devices more than ten fold.  This is further evidence of the success of our land and expand strategy, as having experienced the benefits of the Osirum PxM solution, they have now taken the decision to roll out our technology to public sector customers served by both of their data centres.

 

"We are very pleased that are they providing security services using not only the classic Privileged Acccess Management functionality but also exploiting Osirium's award-winning Task Automation capabilities, for example on Linux devices, to minimise the risk of security breaches."

 

 

– Ends –

For further information:

Osirium Technologies plc	Tel: +44 (0) 118 324 2444
David Guyatt, Chief Executive Officer Rupert Hutton, Chief Financial Officer www.osirium.com
Stifel Nicolaus Europe Limited (Nominated Adviser and Broker)	Tel: +44 (0) 20 7710 7600
Fred Walsh / Neil Shah
Alma PR	Tel +44 (0) 20 3405 0205

Josh Royston, Hilary Buchanan

 

Notes to Editors:

 

About Osirium

 

Osirium Technologies plc (AIM: OSI.L) operates in one of the fastest growing parts of the cybersecurity market and is a leading vendor of Privileged Access Management ("PAM") software. Osirium's cloud-based products protect critical IT assets, infrastructure and devices by preventing targeted cyber-attacks from directly accessing Privileged Accounts, removing unnecessary access and powers of Privileged Account users, deterring legitimate Privileged Account users from abusing their roles and containing the effects of a breach if one does happen.

 

Osirium has defined and delivered what the Directors view as the next generation PAM solution.  The team has developed the concept of a Virtual Air Gap to separate users from passwords.  Built on Robotic Automation technology, Osirium's Privileged Task Management module further strengthens Privileged Account security by minimising the cyber-attack surface and delivering an impressive return on investment benefits for customers.

 

Founded in 2008 and with its headquarters in Reading, UK, the Group was admitted to AIM in April 2016.  For further information please visit www.osirium.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

CNTLIFVAALIFFIA

Close

×

RNS Number : 0212M

Water Intelligence PLC

11 September 2019

 

Water Intelligence plc

Strategic Investment and Partnership

Water Intelligence plc (AIM: WATR.L) ("Water Intelligence" or "Company"), a leading multinational provider of precision, minimally-invasive leak detection and remediation solutions for both potable and non-potable water is pleased to announce a strategic investment in and technology licensing partnership with Entertainment AI Plc ("EAI") (the "Strategic Relationship").

The Strategic Relationship announced today enables Water Intelligence to accelerate its commercial strategy with insurance companies and participate in the fast-growing $13 billion market for "Insuretech" products to minimize water-related claims as underscored in the 2018 Annual Report released in May.

EAI uses proprietary artificial intelligence and machine learning technology to enrich YouTube-length video in order to, among other things, enable consumers to purchase products, such as water monitoring devices, from the video. An example is currently being displayed on the Water Intelligence web site at www.waterintelligence.co.uk. Water Intelligence had previously announced this strategic direction in January 2018 through a technology partnership with EAI's subsidiary, Tagasauris, and Flo Technologies (now FloMoen), a Los Angeles-based water monitoring product company.

EAI is being formed by the acquisition of the Entertainment AI group of companies, comprising Entertainment AI, Inc, GTChannel, Inc and Tagasauris, Inc, (the "EAI US Companies") by Blockchain Worldwide plc ("BLOC"), which was announced today. BLOC has also announced a conditional oversubscribed placing and subscription, including the strategic investment from Water Intelligence, to raise gross proceeds of approximately £8.6 million. Subject to, inter alia, BLOC shareholder approval, admission to trading on AIM and completion of the Company's investment is expected to complete on 30 September 2019. At the time of, or prior to, admission BLOC will be renamed Entertainment AI plc.

The Strategic Relationship will have the following components: 

(i)         £415k investment into EAI effective at admission to AIM of EAI;

(ii)        a global, royalty-free license to EAI technology for the field of use of sustainability and home services audiences in respect of water and infrastructure; and

(iii)       rights, including a Board observer and certain information rights, for so long as Water Intelligence holds 2 per cent. or more of EAI's issued share capital.

Sumitomo Corporation of Japan, a global leader in digital media and an investor in water supply companies around the world, will also be a strategic investor and receive a preferred license.  Other investors in the EAI IPO include existing institutional investors in Water Intelligence.

Water Intelligence Chairman Patrick DeSouza is a substantial shareholder and a co-founder of the EAI US Companies and will serve as non-executive Chairman of EAI. Therefore the Strategic Relationship constitutes a related party transaction in accordance with AIM Rule 13. The Group's independent directors, being Michael Reisman, Laura Hills and David Silverstone, consider, having consulted with its nominated adviser, WH Ireland Ltd, that the terms of the Strategic Relationship are fair and reasonable insofar as its shareholders are concerned.

In addition, Laura Hills, Vice Chairman of Water Intelligence, and Akiko Mikumo, Senior Independent Director of Entertainment AI, will lead any discussions relating to possible future related party matters between Water Intelligence and EAI, consulting the relevant company's nominated adviser and obtaining approval from the Independent Directors of each company.

Water Intelligence's interim financial report will be issued later this month and further details of the Strategic Relationship will be detailed in the report.  The Company continues to perform strongly on its multinational growth plan.

Executive Chairman, Dr. Patrick DeSouza remarked:

"Global market demand for complete solutions to water loss from leakage – both services and products – is strong and only growing.  We are well-positioned and continue to deliver on our articulated plan. We believe our strategic partnership with EAI will enable us to scale more rapidly with a complementary e-commerce, go-to-market plan that complements our physical operations across the United States and in the UK, Australia and Canada.  Our technology reinvestment to build our brand profile as an innovation company continues to progress and will be enhanced with the introduction of an owned and operated YouTube site for sustainability issues. We are on a mission to transform the water infrastructure services market around the world and seek to lead the Insuretech movement."

Enquiries:

Water Intelligence plc
Patrick DeSouza, Executive Chairman	Tel: +1 203 654 5426
Adrian Hargrave, VP Corporate Development	+44 (0) 7775 701 838
WH Ireland Limited – NOMAD & Broker	Tel: +44 (0) 207 220 1666
Adrian Hadden
James Sinclair-Ford
Matthew Chan
Dowgate Capital Ltd Stephen Norcross	Tel: +44(0)20 903 7721 +44 (0)7920 599 793
IFC Advisory Limited Graham Herring Miles Nolan Zach Cohen	Tel: +44(0)20 3934 6630

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

MSCLLFLSAVILLIA

Close

×

RNS Number : 7353L

ValiRx PLC

10 September 2019

 

 

 

 

VALIRX PLC

("ValiRx", the "Company" or the "Group")

 

VAL201 UPDATE

 

"ValiRx announces that in addition to pharmacokinetic and toxicology data, clinical trial results show VAL201 behaves as predicted in reducing prostate cancer progression"

 

London, UK., 10 September 2019: ValiRx Plc (AIM: VAL), the clinical stage biotechnology company, today announces that its lead therapeutic compound, VAL201, has thus far and continues to meet all the published endpoints in its first-in-human study. Following the announced allowance of a substantial amendment in March 2019, the later stages of the trial, where subjects are being given therapeutic and supra-therapeutic concentration of VAL201, continues to demonstrate a safe and well tolerated profile. It should be noted that this is cumulative information and the fact that the compound continues to show a toxicological profile at and above clinical concentration is significant. 

Beyond the fundamental safety and tolerability endpoints for the trial, the study has provided clear pharmacokinetic information about the uptake, distribution, metabolism and elimination of the compound in humans. The data supports and confirms the findings from preclinical and the earliest stages of human studies and in part explains the reduction in prostate cancer progression as measured by PSA – evidence that is supported from tumour imaging (MRI and CT) in subjects.

The effects of the compound on cancer is related to the tumour's exposure to VAL201, and as expected from the underlying mechanism of action, is a complex relationship to the administered dose.  The various amendments to the dosing protocol have allowed this effect to be more fully explored. Further analysis of collected pharmacodynamic samples is progressing and the data is expected to build on this positive outcome to date.  The full data set is currently being reviewed and collated.  Additional data surrounding the possibility of an effect on metastatic tumour lesions is being collated in the few subjects exhibiting such tumours. Such an effect has been seen preclinically and hints are being observed.

The final stages of this first in-human study has provided the information needed to construct a protocol for the late stage trial directed at determining effective dosing regimes for clinical use and will explore the full extent of the compound's utility in clinical practice.

 

This phase I/II trial will be finalised as expected from a regulatory viewpoint while the new VAL201 confirmatory trial is developed and aimed at validating the most effective treatment regime and its particular use in clinical practice. Data relating to the pharmacology, pharmacokinetics and pharmacodynamics will be published as it is collated, verified and submitted.

VAL201 has been developed in collaboration with Cancer Research (CRUK) and is a decapeptide with potential in treating hormone-dependent and hormone-independent prostate cancer, currently a poorly served multi-billion dollar commercial market.

Dr Satu Vanikka, CEO of ValiRx Plc, commented:

 "We are delighted that our Phase I/II trial of VAL201 has met its endpoints very well and that we are now able to use our peptide in demonstrating the efficacy of the VAL201 compound as a therapeutic product that has a large role to play in dealing with what is a nasty set of conditions in a better and more patient friendly way."

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

*** ENDS ***

 

For more information, please contact:

 

ValiRx plc	Tel: +44 (0) 20 3008 4416 www.valirx.com
Dr Satu Vainikka, Chief Executive	Tel: +44 (0) 20 3008 4416
Tarquin Edwards, Head of Communications.	Tel: +44 (0) 7879 458 364 [email protected]
Cairn Financial Advisers LLP (Nominated Adviser) Liam Murray / Jo Turner/ Ludovico Lazzaretti	Tel: +44 (0) 20 7213 0880
Novum Securities Limited Colin Rowbury	Tel: +44 (0) 20 7399 9400

 

Notes for Editors

About ValiRx

ValiRx is a biotechnology oncology focused company specialising in developing novel treatments for cancer and associated biomarkers. It aims to make a significant contribution in "precision" medicine and science, namely to engineer a breakthrough into human health and well-being, through the early detection of cancer and its therapeutic intervention.

 

The Company's business model focuses on out-licensing therapeutic candidates early in the development process. By aiming for early-stage value creation, the company reduces risk considerably while increasing the potential for realising value. The group is already in licensing discussions with major players in the oncology field.

 

ValiRx's two classes of drugs in development, which each have the potential for meeting hitherto unmet medical needs by existing methods, have worldwide patent filings and agreed commercial rights.   They originate or derive from World class institutions, such as Cancer Research UK and Imperial College. 

 

Until recently, cancer treatments relied on non-specific agents, such as chemotherapy.  With the development of target-based agents, primed to attack cancer cells only, less toxic and more effective treatments are now possible. New drugs in this group-such as those in ValiRx's pipeline-promise to greatly improve outcomes for cancer patients.

 

The Company listed on the AIM Market of the London Stock Exchange in October 2006 and trades under the ticker symbol: VAL.

 

Caution regarding forward looking statements

Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', "expect", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors. 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

UPDLFFLIAFIAIIA

Close

×

RNS Number : 4341L

EVR Holdings PLC

06 September 2019

 

 

EVR Holdings plc

('EVR' or the 'Company')

 

MelodyVR Successfully Completes Simultaneous TV and VR Broadcast in Partnership With Good Morning America, Marshmello and Kane Brown. 

 

EVR Holdings plc (AIM:EVRH), the leading creator of virtual reality entertainment content and operator of the MelodyVR platform, is pleased to announce streaming statistics in connection with MelodyVR's partnership with American Broadcasting Companies, Inc ("ABC") and Good Morning America ("GMA") to deliver a milestone media event on August 30th: a live, immersive broadcast of GMA's Summer Concert Series, featuring Mashmello and Kane Brown live from New York's Central Park.

This first-of-a-kind broadcast, which simultaneously featured across national television and in 360/virtual reality, received over 100,000 live streams via the MelodyVR app alone. The broadcast repeated throughout the United States, in tandem with the airing of GMA in additional timezones, seeing fans access the MelodyVR platform on EST, CST, MST and PST time and throughout all 50 US States. The content was also simulataneously consumed by users in 14 additional countries across the globe.

In the week prior to the event, multiple segments, including live on-air showcases took place on GMA, reaching a live TV audience in excess of 4 million daily viewers. A promotional segment on Melody, was also broadcast on a large number of ABC's 238 affiliate channels across the US, reaching tens of millions of additional US consumers.  The successful event harnessed the combined social media following of Marshmello, Kane Brown and GMA, which was in excess of 62 million and this has extensively increased brand awareness of the MelodyVR platform in the United States and beyond. With the on-demand show now live and accessable on MelodyVR, fans can go back and re-live the performance again and again.

Anthony Matchett, CEO and Executive Chairman of EVR Holdings PLC said:

"The simultaneous broadcast of Marshmello and Kane Brown's performance as part of GMA's summer concert series was a world first for both traditional television broadcast and for MelodyVR. The event was extremely successful and has subsequently exposed MelodyVR to millions of households, spanning all corners of the United States, endorsed by prominent featuring across America's #1 morning TV show. We look forward to working more closely with both ABC and GMA in future."

 

www.melodyvr.com

@melodyvirtual

For further information please contact: EVR Holdings plc Anthony Matchett, Executive Chairman & CEO                                         [email protected]

Arden Partners plc: Nominated Advisor and Sole Broker                          Tel: +44 (0) 20 7614 5900 Corporate Finance: Ciaran Walsh / Ruari McGirr / Ben Cryer Corporate Broking: Simon Johnson Notes to Editors:

Melody VR launched in 2018 with a simple mandate: not to replace the live experience, but to harness the power of virtual reality to get people closer to the music they love. By using VR technology, the founders realized that they could place fans in the crowd or on-stage with their favorite musicians at live events. From epic stadium shows to intimate studio performances, the possibilities are endless; Capacity restrictions are eliminated, music fans can attend otherwise sold-out dates, and the barriers (distance, age, cost, access) that might keep people from the experiencing their chosen artists live are swept away. The result? Artists can reach more fans than ever before with a level of intimacy which has previously never been possible. MelodyVR is the only licensed VR music platform and has the world's largest library of immersive and interactive music experiences from the likes of Post Malone, Blake Shelton, Wiz Khalifa, Kelly Clarkson, Niall Horan, Fall Out Boy, Bebe Rexha, The Chainsmokers and Imagine Dragons. MelodyVR is a wholly owned subsidiary of EVR Holdings plc ('EVR'), a company that is listed on the AIM market of the London Stock Exchange under the ticker EVRH.L.

For more information on Melody VR, please visit: www.melodyvr.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

UPDCKADBBBKKACK

Close

×

RNS Number : 6875K

Shearwater Group PLC

30 August 2019

 

RNS REACH

30 August 2019

 

SHEARWATER GROUP PLC

 

SecurEnvoy signs distribution agreement with EMT Distribution

 

Shearwater Group plc, the organisational resilience group, announces that its group company, SecurEnvoy, has signed a distribution agreement with EMT Distribution, the specialised cyber security software distributor.

 

EMT Distribution will represent SecurEnvoy as a distribution partner for its existing Multi-Factor Authentication ("MFA") solutions, as well as other future product categories, in the Middle East, Turkey and Africa ("META").

 

SecurEnvoy develops innovative identity and access management solutions to protect the user, device and data, enabling organisations to deploy a wide range of methods to authenticate users accessing Microsoft Office 365 web and desktop applications.

 

EMT Distribution's third party solutions are sold and supported throughout the Asia Pacific region, Europe, Middle East and Africa.

 

Phil Higgins, CEO of Shearwater Group plc, commented:

 

"EMT Distribution is well positioned to accelerate growth across the META region for SecurEnvoy's product set, in particular its MFA-as-a-Service, which integrates with its on-premise MFA solution.

 

"This agreement opens up an additional distribution channel for SecurEnvoy and strengthens its position in the identity and access management sector." 

 

Mohd Mobasseri, CEO of EMT Distribution, added:

 

"Our distribution agreement with SecurEnvoy is a real testament to the value of our channel, particularly as we continue to build global support around our network.

 

"SecurEnvoy has a fantastic technology and we look forward to seeing how we can support the growth of the business across the Middle East, Turkey, and Africa. We are very proud to start this new relationship."

 

Enquiries:

 

Shearwater Group plc David Williams, Chairman Phil Higgins, CEO	c/o Instinctif Partners
Instinctif Partners Adrian Duffield / Chantal Woolcock	[email protected]   +44 (0) 20 7457 2815

 

 

About Shearwater Group plc

 

Shearwater Group plc is an award-winning organisational resilience group that provides cyber security and managed security services to help assure and secure businesses in a connected global economy.

 

The Group's comprehensive cyber security solutions and services maintain trust between users, provide assurance around the protection of information assets and critical infrastructure, and support organisations' operational effectiveness.  Its capabilities include identity and access management and data security, cyber security solutions and managed security services, and security governance, risk and compliance.

 

The Group is headquartered in the UK with offices in the US, UK and Europe, serving customers across the globe who are active in a broad spectrum of industries.

 

Shearwater shares are listed on the London Stock Exchange's AIM under the ticker "SWG".  For more information, please visit www.shearwatergroup.com.

 

SecurEnvoy is a wholly owned subsidiary of Shearwater Group plc. It provides trusted identity and access management solutions to millions of users in real-time. Fast deployment across any environment, SecurEnvoy's technology maintains trust between those users and ensures the protection of organisations' critical data and infrastructure. For more information, please visit www.securenvoy.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

NRAPMMRTMBMJMFL

Close

×

RNS Number : 2567K

Proton Power Systems PLC

27 August 2019

 

 

 

 

 

 
Proton Power Systems plc

("Proton" or the "Company")

 

Joint venture

 

Proton Power Systems plc (AIM: PPS), the designer, developer and producer of fuel cells and fuel cell electric hybrid systems with a zero-carbon footprint, announces that it has entered into a joint venture agreement with Schäfer Elektronik GmbH ("Schäfer Elektronik") whereby the two companies will integrate Proton's larger industrial fuel cells with Schäfer's power electronics, battery and a hydrogen storage systems in one integrated plug and play power unit. This unit will provide in excess of 1 MW of power to supply electric vehicle charging stations and will be available either as standalone unit or as grid connected unit, which would also be able to support the local grid if required.

 

The Board expects support across Europe and the UK for the electric car industry to rapidly increase by 2021 leading to demand for electric vehicle charging stations. In order to achieve a zero carbon footprint and to avoid national grid overload, these charging stations are highly likely to be powered by hydrogen fuel cells in order to supply the required electric load without undue stress on the electrical grid. 

 

Mr Schäfer, CEO of Schäfer Elektronik, commented: "We are delighted to contribute to saving our planet from some of the effects of global warming; our technology will always endeavour to improve the world to live in."

 

For further information:

Proton Power Systems plc
Dr Faiz Nahab, CEO Helmut Gierse, Chairman Sebastian Goldner, COO/CTO Roman Kotlarzewski, CFO Manfred Limbrunner, Director Sales and Marketing	Tel: +49 (0) 173 189 0923   www.protonpowersystems.com
Shore Capital Nominated adviser and broker
Antonio Bossi / David Coaten	Tel: +44 (0) 20 7408 4050 www.shorecap.co.uk

About Proton Motor Fuel Cell GmbH

Proton Motor has more than 20 years of experience in Power Solutions using CleanTech technologies such as hydrogen fuel cells, fuel cell and hybrid systems with a zero carbon footprint.  Based in Puchheim near Munich, Proton Motor offers complete fuel cell and hybrid systems from a single source – from the development and production through the implementation of customized solutions.  The focus of Proton Motor is on back-to-base, for example, for mobile, marine and stationary solutions applications.  The product portfolio consists of base-fuel cell systems, standard complete systems, as well as customized systems.

 

Proton Motor serves IT, Telecoms, public infrastructure and healthcare customers in Germany, Europe and Middle East with power supply solutions for DC and AC power demand. In addition to power supply, Proton Motor also offers solutions for Solar Systems as well as Solar Energy Storage.

 

Proton Motor Fuel Cells GmbH is wholly owned subsidiary of Proton Power Systems plc. The Company has been quoted on the AIM market of the London Stock Exchange since October 2006 (code: PPS).

 

About Schäfer Elektronik GmbH

Schäfer Elektronik is a manufacturer with almost 50 years' experience in design and production of Power Supply Systems for industrial applications, with particular focus on oil and gas, defence, industrial automation, power generation, rail and automotive segments.

With its headquarters in South-Germany, a production facility in Ireland and sales offices in USA and UAE as well as numerous representatives, Schäfer Elektronik possesses a comprehensive worldwide sales network.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

JVELIFETTTIDFIA

Close

×

Neville Registrars is delighted to welcome iWater Group Limited as the newest addition to its list of client companies.

iWater Group Limited is a water disinfection and decontamination solutions company engaged in the development and delivery of effective, environmentally friendly products for a diverse range of industry sectors, ranging from oil and gas, drinking water, shipping and manufacturing, to farming and livestock.

Further information can be found on the Company's website: https://www.iwatergroup.com

Close

×

RNS Number : 9473I

Osirium Technologies PLC

14 August 2019

 

 

 

 

14 August 2019

 

 

Osirium Technologies plc

 

("Osirium" or "Group")

 

First contract win for Opus

 

 

Osirium (AIM: OSI), a leading vendor of cloud-based cybersecurity software, is pleased to announce the first customer for its new innovative privileged robotic process automation solution, Opus, which was launched in May of this year.

The contract is with a leading asset manager who recently renewed Osirium's full PxM platform for a further three-year term, as announced in May. The customer selected Opus to reduce manual processes, speed up internal customer service and improve consistency of service. Up until now, IT administration operations, such as creating or updating user and system accounts, are repeated many times per day, taking up to an hour each to complete and needing senior staff involvement. End-users become frustrated because of delays in provisioning or updating accounts, with execution of changes proving inconsistent, and the IT organisation wanting to free up resource to deliver business changes faster.

Opus will augment the client's existing ServiceNow infrastructure to automate these tasks. Now, less-experienced IT engineers can perform software updates securely and reliably, with tasks being completed accurately and efficiently in just a few minutes. This will result in improved customer satisfaction, consistency and reporting, and capacity in the team will be freed up to allow more experienced staff to focus on delivering higher-value business initiatives.

David Guyatt, Chief Executive Officer, commented: "Osirium's privileged account security strategy has been significantly strengthened with the launch of two more privileged security products, Opus and PEM which, together with Osirium's PxM platform, maximise our ability to combat privileged security threats, wherever the security concerns may be. This contract is an excellent example of how we can broaden our relationship with existing customers as they appreciate the quality of our products, their ease of implementation and the benefits that they can deliver. Opus has wide applicability and is generating interest across DevOps, NetOps and outside IT in business teams."

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 ("MAR"). Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

 

For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is being made on behalf of the Company by David Guyatt, CEO.

 

– Ends –

 

For further information:

Osirium Technologies plc	Tel: +44 (0) 118 324 2444
David Guyatt, Chief Executive Officer Rupert Hutton, Chief Financial Officer www.osirium.com
Stifel Nicolaus Europe Limited (Nominated Adviser and Broker)	Tel: +44 (0) 20 7710 7600
Fred Walsh / Neil Shah / Alex Price
Alma PR (Financial PR)	Tel: +44 (0) 20 405 0210
Hilary Buchanan / Josh Royston / Kieran Breheny

 

Notes to Editors:

 

About Osirium

Osirium Technologies plc (AIM: OSI) operates in one of the fastest growing parts of the cybersecurity market and is a leading vendor of Privileged Access Management ("PAM") software. Osirium's cloud-based products protect critical IT assets, infrastructure and devices by preventing targeted cyber-attacks from directly accessing Privileged Accounts, removing unnecessary access and powers of Privileged Account users, deterring legitimate Privileged Account users from abusing their roles and containing the effects of a breach if one does happen. 

 

Osirium has defined and delivered what the Directors view as the next generation PAM solution.  The team has developed the concept of a Virtual Air Gap to separate users from passwords.  Built on Robotic Automation technology, Osirium's Privileged Task Management module further strengthens Privileged Account security by minimising the cyber-attack surface and delivering an impressive return on investment benefits for customers.   Building on Osirium's Privileged Task Management module, in May 2019 Osirium launched "Opus", providing a highly-flexible platform for automating essential IT processes to set a new benchmark in Privileged IT Process Automation.

 

Founded in 2008 and with its headquarters in Reading, UK, the Group was admitted to AIM in April 2016.  For further information please visit www.osirium.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

CNTZMGMRGFLGLZZ

Close

×

RNS Number : 6231I

DeepMatter Group PLC

12 August 2019

 

 

Launch of DigitalGlassware™ Online Portal

First look at the uniquely rich, contextualised experiment data recorded by DigitalGlassware™, aiming to solve the reproducibility problem in chemistry

 

12 August 2019 – DeepMatter, the AIM-listed company at the forefront of digitizing chemistry, today announces the launch of its open access DigitalGlasswareTM online portal, which allows the scientific world to view and interact with the shareable data originated from chemistry lab experiments conducted using DeepMatter's proprietary technology.

 

The online portal allows individuals to visualise and interact with the uniquely contextualised, rich and real-time data that DeepMatter's innovative cloud-based platform (DigitalGlassware™) generates recording experiments. This includes data points such as temperature, UV light levels, pressure and more.

 

To demonstrate the capabilities of the technology, the DigitalGlasswareTM online platform has today been populated with the data from an example experiment: a selective amination of an alcohol under mild conditions.

 

Going forward, the portal will be regularly updated with the outcomes of other experiments, showing how DigitalGlassware™ works under real reaction scenarios and, crucially, how it can save time and money and increase lab productivity. These will be supported by blog post 'data stories', providing guidance to help users familiarise themselves with DigitalGlassware™.

 

The online portal can be found at https://public.deepmatter.tech;

and the associated blog post at: https://www.deepmatter.io/blog

 

This one example is a demonstration of the depth of data that will ultimately be openly accessible across an increasing library of experiments through the DigitalGlasswareTM digital platform.

 

This level of data sharing will allow scientists to re-create experiments to a greater degree of accuracy. Ultimately, the aim is to solve the billion-dollar reproducibility problem.

 

The portal will be consistently developed and refined, with chemists eventually able to upload their own 'recipes' and run data through the portal.

 

Mark Warne, CEO of DeepMatter, commented:

 

"This is a fantastic opportunity to demonstrate our DigitalGlassware™ platform to a broader audience of chemists. Our aim is for our software to become truly integral to research and process chemistry, providing those involved with a cost-effective, easy-to-use solution that will save significant time, effort and money. The launch of this platform is a significant step towards achieving the sharing and recording of detailed data in real time across the chemistry industry, making reproducibility much more achievable."

 

About DeepMatter

 

DeepMatter Group Plc is a big data and analysis company which has built a technology platform – DigitalGlassware™, focused on enabling reproducibility in chemistry. It continues to develop this software to deliver applications resulting in new optimised chemicals, materials and formulations in such commercially significant areas as pharmaceutical research, fine chemicals, scientific publications and teaching. DeepMatter is at the forefront of the digitization of chemistry, which will ultimately see the enabling of an autonomous synthesis engine, the Chemputer™.

 

Paying clients of the DigitalGlasswareTM platform are able to nominate which data remains proprietary, for their sole use, and which can be made shareable via the Online Portal.

Visit: www.deepmatter.io and follow @deepmattergroup

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

NRAPLMATMBJMBRL

Close

×

RNS Number : 2639I

Avanti Communications Group Plc

07 August 2019

 

7 August 2019

Avanti Communications Group plc
 

Successful Launch of HYLAS 3

 

Avanti Communications Group PLC (AIM: AVN) ("Avanti" or the "Company"), a leading provider of satellite data communications services in Europe, the Middle East and Africa, announces the successful launch of HYLAS 3 from Kourou, French Guiana on Ariane Flight VA249 on Tuesday 6 August 2019.

The Ariane 5 rocket launched HYLAS 3 into its correct orbit on schedule. HYLAS 3 successfully separated from the Ariane 5 rocket on time and telemetry was received by the control centre at the European Spaceport. 

HYLAS 3 is a hosted Ka-band communications payload on board the EDRS-C satellite – a public private partnership between the European Space Agency and Airbus.  This is the second successful launch of an Avanti payload in as many years and brings total fleet capacity over EMEA to 50 GHz.

Kyle Whitehill, Chief Executive of Avanti, said:

"I'm pleased to announce HYLAS 3 has been successfully launched thereby completing our capital expenditure cycle. The satellite will undertake a series of pre-planned in-orbit acceptance tests over the coming months before we commence service for customers."

 

For further information, please contact:

Avanti Communications	Nigel Fox Tel: +44 (0)20 7749 1600
Cenkos Securities (Nomad)	Max Hartley, Katy Birkin Tel: +44 (0)20 7397 8900
Newgate Communications	Adam Lloyd Tel: +44 (0)20 3757 9842

 

About Avanti

Avanti connects people wherever they are. Through the HYLAS satellite fleet and partners in 118 countries, our network provides ubiquitous internet service to an end market of over 1.7bn people. Avanti works together with like-minded people and organisations to go the extra mile, developing new, innovative and pioneering satellite solutions that help to liberate the potential of people, businesses and government departments across EMEA. We have invested $1.2bn in the latest Ka-band satellite technology and shaped it to meet our customers' aspirations.

Avanti is listed in London on AIM (AVN: LSE). www.avantiplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

MSCBGGDIXDGBGCR

Close